Erudexa Publishing

1. What CC BY 4.0 means (plain language)

• Anyone may copy, redistribute, display and perform the work, and make derivative works (adaptations) for any purpose, including commercial use.
• Attribution required: Reusers must give appropriate credit, provide a link to the licence, and indicate if changes were made.
• No additional restrictions: Reusers may not apply legal terms or technological measures that legally restrict others from doing anything the licence permits.
• Translations and adaptations: Allowed under CC BY 4.0 if attribution and change-notice are provided.

For full legal text see: https://creativecommons.org/licenses/by/4.0/

2. Copyright ownership & the publisher’s role

• Authors keep copyright. Erudexa does not require transfer of copyright.
• By submitting and signing the publishing agreement, authors grant Erudexa a non-exclusive licence to publish and distribute the accepted manuscript and the final published version, to deposit copies in archives (Zenodo / Internet Archive / SSRN), and to claim authorship on the publisher’s platform for discoverability purposes.
• Erudexa will publish the article under CC BY 4.0 and will clearly display licence and copyright information on the article page and in article metadata.

3. What authors must declare and supply

• Confirm authorship and copyright status: Authors must confirm they are the copyright holders or have secured rights from copyright holders for all material included.
• Third-party material: Any material not created by the authors (figures, long quotations, tables, images, multimedia) must be clearly identified and accompanied by written permission from the rights holder for inclusion under CC BY 4.0 — unless the third-party material is already compatible with CC BY, in the public domain, or used under fair use/exceptions (authors should supply documentation).
• Moral rights & modifications: Authors should expect that minor editorial changes, formatting and metadata enhancements may be made for publication, indexing and archiving. Authors agree to reasonable edits required for clarity, typesetting and compliance with indexing metadata.

4. Recommended licence statement (use on article and title page)

Authors should include the following short statement on the title page and in their submission metadata:

© [Year] [Author(s)]. This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Erudexa will display the licence badge and full licence link on the published article page.

5. Attribution best practice (what reusers must do)

When reusing or adapting content under CC BY 4.0, the following information should be provided (where practicable):

1. Author(s) — name(s) of the original author(s).
2. Title — the original article title.
3. Source — link or DOI to the original published version (e.g., DOI via Zenodo).
4. Licence — “CC BY 4.0” with a link to the licence text.
5. Changes — a brief note describing any adaptations (e.g., “Translated from English; figure adapted from…”).

Example attribution:
“Smith J, Kumar P. Title of Article. Erudexa Publishing; 2025. DOI:10.5281/zenodo.xxxxxx. Licensed under CC BY 4.0. Adapted with permission.”

6. Third-party content, permissions & responsibility

• Responsibility: Authors are responsible for obtaining and supplying written permission for any third-party content not covered by CC BY or public domain. Permissions must be sufficient to allow the material to be published under CC BY 4.0 on the publisher platform and in archival deposits.
• How to document permissions: Upload permission letters during submission and identify third-party content clearly in captions and credit lines. Failure to obtain required permissions may delay publication or require removal of the material.

7. Licensing of data, code and supplementary materials

• Articles: Covered by CC BY 4.0 by default.
• Data & code: Authors should clearly state the licence for underlying data and code. Erudexa encourages open data; recommended licences include CC0 (public domain dedication) or CC BY 4.0 for datasets, and permissive open-source licences (e.g., MIT, Apache 2.0) for code. If authors choose restrictive licences for data or code, they must declare them in the Data Availability Statement.
• Repository deposition: Authors are encouraged to deposit datasets and code in recognized repositories and supply persistent identifiers (DOIs). Erudexa will record these identifiers in article metadata and archive copies where appropriate.

8. Commercial reuse & downstream licensing

• Commercial reuse allowed: CC BY 4.0 permits commercial reuse. If authors or institutions wish to restrict commercial re-use, alternative licences must be negotiated before submission and clearly agreed with the publisher (rare and may affect indexing eligibility). Erudexa’s default, indexer-friendly approach is CC BY 4.0.

9. Licence metadata & machine-readable fields

Erudexa appends standard machine-readable licence metadata to every published article to support discovery and indexing. Example metadata fields we use:

• dc.rights — “CC BY 4.0”
• dc.rights.uri — http://creativecommons.org/licenses/by/4.0/
• dc.rightsHolder — “[Author(s) name(s)]”
• dc.identifier — DOI assigned via Zenodo (e.g., 10.5281/zenodo.xxxxxx)
• dc.type — article / review / data paper etc.

Authors must supply correct metadata at submission (author names, ORCIDs, affiliations) to ensure accurate licence attribution.

10. Requests for permission beyond CC BY 4.0

• No permission needed for uses allowed by CC BY 4.0. For uses that go beyond the licence (for example, requests for moral-rights waivers in jurisdictions where those rights cannot be waived), or if a reuser wants a formal permission letter from Erudexa, contact contact@erudexapublishing.com with full details of the intended use. Erudexa will respond and — where appropriate — issue permission letters; fees may apply for administrative processing for extraordinary requests.

11. Corrections, takedown & legal concerns

• Corrections & retractions: Licensing does not prevent corrections or retractions. If an article is corrected or retracted, the licence statement remains but is accompanied by linked notices explaining the change.
• Takedown requests & legal claims: Requests based on alleged copyright infringement, defamation or legal claims should be sent to contact@erudexapublishing.com with full details and supporting documentation. Erudexa will follow a documented process to assess and, if necessary, act on lawful requests while balancing the openness of the scholarly record and legal obligations.

12. Why this approach supports indexing & discoverability

• CC BY 4.0 is widely recognised and preferred by many indexers and funders because it maximizes reusability and metadata clarity. By retaining author copyright while publishing under CC BY 4.0, Erudexa ensures compliance with open-access standards required by resources such as DOAJ and other indexers, supports automated harvesting, and enables broad scholarly reuse.

13. Practical checklist for authors (copyright & licence)

• Confirm you hold copyright or have permission for all included material.
• Supply written permissions for third-party material not covered by CC BY or public domain.
• Include the recommended licence statement on the title page.
• Declare licence for underlying data and code.
• Provide complete metadata (authors, ORCIDs, affiliations) for machine-readable rights tagging.
• Contact contact@erudexapublishing.com for any special permission queries.

14. Contact for rights, permissions & legal enquiries

Rights & Permissions — Erudexa Publishing
Email: contact@erudexapublishing.com · editorial@erudexapublishing.com
Phone: +91 6001635710
Please include: article title (or manuscript ID), author name(s), DOI (if published), a clear description of the request and any supporting documentation.